logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11820792 B1

PDFFull Text
Date of Patent:
Nov. 21, 2023

Filed:

Apr. 24, 2018

Cancer treatment

Applicant:

Imperial College Innovations Limited, London, GB;

Inventors:

Amin Hajitou, London, GB;

Keittisak Suwan, London, GB;

Mariam Albahrani, London, GB;

Sajee Waramit, London, GB;

Assignee:

Imperial College Innovations Limited, London, GB;

Attorneys:

Linda B. Huber

Nixon Peabody LLP

Primary Examiner:

Maria Marvich

Int. Cl.
CPC ...
A61K 48/00 (2006.01); A61K 35/76 (2015.01); A61K 38/20 (2006.01); C12N 7/01 (2006.01); C12N 15/11 (2006.01); C12N 15/19 (2006.01); C12N 15/86 (2006.01); C07K 14/525 (2006.01); C07K 14/54 (2006.01); C12N 7/00 (2006.01); A61K 38/00 (2006.01); A61K 33/243 (2019.01);
U.S. Cl.
CPC ...
C07K 14/525 (2013.01); C07K 14/5406 (2013.01); C07K 14/5434 (2013.01); C12N 7/00 (2013.01); C12N 15/111 (2013.01); C12N 15/86 (2013.01); A61K 33/243 (2019.01); A61K 38/00 (2013.01); C07K 2319/02 (2013.01); C12N 2750/14143 (2013.01); C12N 2750/14152 (2013.01); C12N 2750/14171 (2013.01); C12N 2800/202 (2013.01); C12N 2800/24 (2013.01); C12N 2800/50 (2013.01); C12N 2810/405 (2013.01); C12N 2820/60 (2013.01);
Abstract

The present invention provides phagemid vectors and associated phagemid particles for cancer treatment, and in particular, to the use of novel phagemid particles and associated expression systems for the treatment, prevention, amelioration, or management of cancer. In particular, the invention relates to the use of phagemid particles and expression systems for the delivery of transgenes encoding cytokines, for the treatment, prevention, amelioration, or management of cancer. The invention also extends to the use of phagemid particles and expression systems for the delivery of transgenes, and for the combination of such treatment with the use of adoptively transferred T cells, for the treatment, prevention, amelioration, or management of cancer.

Find Patent Forward Citations

Quick Actions:

Hajitou, Amin. (2023). Cancer treatment (U.S. Patent No. 11820792). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11820792

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…